SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-024075
Filing Date
2019-04-26
Accepted
2019-04-26 16:11:55
Documents
5
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2649_3defa14a.htm DEFA14A 32881
2 GRAPHIC g26493bci001.gif GRAPHIC 66888
3 GRAPHIC g26493bci002.gif GRAPHIC 99817
4 GRAPHIC g26493bci003.gif GRAPHIC 35884
5 GRAPHIC g26493bci004.gif GRAPHIC 3477
  Complete submission text file 0001104659-19-024075.txt   318076
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37687 | Film No.: 19771883
SIC: 2836 Biological Products, (No Diagnostic Substances)